Margot Lazow is a Glioma Diagnosis and Treatment physician affiliated with Nationwide Children's Hospital. OpenAlex indexes 85 publications with 1,120 citations (h-index 15); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 25 Oct 2026
Overview
Updated 27 Oct 2026
Margot Lazow, M.D., is affiliated with Nationwide Children's Hospital. The public record shows 85 publications with 1,120 citations (h-index 15), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Cancer Genomics and Diagnostics. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2022–2025).
- Most recent indexed publication: 2025 · Cancers
- Top research focus: Glioma Diagnosis and Treatment
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 21.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Sponsor: Nationwide Children's Hospital
- Targeted Pediatric High-Grade Glioma Therapy
Sponsor: Nationwide Children's Hospital
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Sponsor: Nationwide Children's Hospital
Industry payments
Updated 26 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Day One BiopharmaceuticalsProgram year20251 payment
NIH funding
Updated 26 Oct 2026
2 NIH research awards on record, funded 2022–2025 per NIH RePORTER. The latest:
- Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma
Research Inst Nationwide Children'S Hosp
FY2025$3,218,733R01FD008167 - Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]
Research Inst Nationwide Children'S Hosp
FY2024$485,894R01FD007532 - Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]
Research Inst Nationwide Children'S Hosp
FY2022$784,837R01FD007532
Congress activity
Updated 26 Oct 2026
2 congress contributions (2022–2025) across ASCO, ASTRO per OpenAlex. The most recent:
- Risk of Secondary Malignant Neoplasms in Children Following Proton Therapy vs. Photon Therapy for Primary CNS Tumors
ASTRO Annual Meeting
ASTRO2022Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings.
JCO precision oncology
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02The Transition Zone between Healthy and Diseased Retina in Patients with Retinitis PigmentosaArticle160 citations2010
- 03Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosaArticle101 citations2011
- 04
- 05
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
pnoc.us
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pnoc.us ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Maryam Fouladi, MD
Nationwide Children's Hospital
Toshiharu Shinoka, MD
Nationwide Children's Hospital
William Smoyer, MD
Nationwide Children's Hospital
Mark Galantowicz, MD
Nationwide Children's Hospital
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center